BRH.L Stock Analysis
BR
Uncovered
Braveheart Investment Group PLC is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Market cap $B
0.004
Dividend yield
380.00 %
Shares outstanding
63.724 B
Braveheart Investment Group Plc engages in the provision of debt or equity and advisory services. The company is headquartered in Barnsley, South Yorkshire and currently employs 7 full-time employees. The company went IPO on 2007-03-30. The firm divides its investments into two categories, namely Strategic Investments and Portfolio Investments. Its Strategic Investments contain five companies: Gyrometric Systems Limited, Kirkstall Limited (Kirkstall), Paraytec Limited (Paraytec), PhaseFocus Holdings Limited (Phasefocus) and Sentinel Medical Limited. Paraytec develops specialist detectors for the analytical and life sciences instrumentation markets. Phasefocus has developed a series of patented computational imaging and analysis techniques, which have a range of applications, including live-cell imaging, engineering metrology and electron microscopy. Kirkstall operates in the market known as organ-on-a-chip, where it has developed Quasi Vivo, a system of chambers for cell and tissue culture in laboratories. Its portfolio investments include Autins Group plc, Velocity Composites plc, Binx Health Ltd. and other.